Mrs. Margaret Gottschalk, OTR/L, M.ED Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 28 Danby Way, Langhorne, PA 19047 Phone: 215-750-1382 |
Patrick Costello, D.OT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 125 Pine Glen Rd, Langhorne, PA 19047 Phone: 215-696-3937 |
Alyson Elizabeth Miller, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 E Winchester Ave, Langhorne, PA 19047 Phone: 888-531-2204 Fax: 855-232-8604 |
Kaitlin Wylie, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 Trenton Rd # E123, Langhorne, PA 19047 Phone: 267-981-4797 |
Kathryn Stern, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 40 Martin Drive, Langhorne, PA 19047 Phone: 215-750-4304 |
Mrs. Brenda Marie Finn, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Crestview Center 262 Tollgate Rd., Langhorne, PA 19047 Phone: 215-757-4000 |
Ms. Emily Schooley, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 262 Tollgate Rd, Langhorne, PA 19047 Phone: 215-968-4650 |
Mrs. Jennifer Wyckoff, MSOTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 350 Manor Ave, Langhorne, PA 19047 Phone: 215-757-7667 Fax: 215-750-1426 |
Kristina Pena Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 262 Tollgate Rd, Langhorne, PA 19047 Phone: 267-757-4012 |
William Moretti, OTR-L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1203 Langhorne Newtown Rd Ste 220, Langhorne, PA 19047 Phone: 609-896-0444 |
Lorraine Calhoun, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3 Cornerstone Dr, Suite 700, Langhorne, PA 19047 Phone: 215-750-0501 |
Meghan Lee Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 E Winchester Ave, Langhorne, PA 19047 Phone: 215-757-3739 |
Mr. Daniel Joseph Gasiewski, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 262 Tollgate Rd, Langhorne, PA 19047 Phone: 267-757-4000 |
Dominick Delprete Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 262 Tollgate Rd, Langhorne, PA 19047 Phone: 215-968-4650 |
Ms. Jennifer Anne Kitchen, MS, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1203 Langhorne Newtown Rd Ste 335, Langhorne, PA 19047 Phone: 610-768-5940 Fax: 610-768-5947 |
Mrs. Melissa Marie White, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 262 Tollgate Rd, Langhorne, PA 19047 Phone: 267-757-4012 |
Mrs. Sandra Regina Moyer, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 518 Newport Cir, Langhorne, PA 19053 Phone: 215-396-1051 Fax: 215-322-6997 |
Sally Jegier, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 350 Manor Ave, Langhorne, PA 19047 Phone: 215-757-7667 Fax: 215-750-1426 |
Ms. Michelle Marie Hediger, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 147 W Marshall Ave, Langhorne, PA 19047 Phone: 516-456-8356 |
Apple A Day Ot Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 206 Corporate Dr E, Langhorne, PA 19047 Phone: 215-630-4221 |
News Archive
China Biologic Products, Inc., one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, today announced that it has received the permit from the Shandong Province Health Department for the newly built plasma collection station in Ningyang County, Shandong Province, and expects to begin commercial plasma collection at the Ningyang station on July 12, 2011.
Schizophrenia is a potentially debilitating mental illness affecting a person's thought processes, perception, language and sense of oneself.
A recently opened double- blind phase III EORTC trial 1325 will prospectively assess whether post-operative adjuvant therapy with pembrolizumab, an anti-PD-1 monoclonal antibody, improves recurrence-free survival as compared to placebo in patients with high-risk stage III melanoma.
Valeant Pharmaceuticals International announced today that it has priced its previously announced private placement of $400 million of 7.625% senior unsecured notes due 2020. The principal amount was increased from the previously announced $350 million.
› Verified 9 days ago